The Texas hemp industry was dealt a blow today after a bill that would ban delta-8 and all isomers advanced out of a senate committee hearing.
Unfortunately, Sen. Charles Perry (R-Lubbock), who is the driving force behind this ban, made it clear from the start of the hearing that no testimony would change his mind.
As multiple business owners provided comment about the harmful impact such a ban would have on the supply chain, Sen. Perry was rudely checking his phone, conversing with aids, and generally not paying attention. When he did chime in, it was to interrupt whoever was speaking to try and emphasize his own opinions. It was an incredibly close-minded hearing.
What was even more appalling was when he made a comment comparing the industry's embrace of Delta-8 to that of a "drug cartel."
Sen. Perry's office deserves to hear from the industry concerning his behavior during the hearing.
Despite almost exclusively negative feedback, the ban was passed out of committee, along with the rest of the hemp bill.
Next, the bill heads to calendars to be scheduled for debate on the senate floor. The senate has to vote on the bill, and if any changes are adopted from the house version (the delta-8 ban is a major change), then it must head to conference committee to be negotiated, and then must be approved by the House again. From there, it heads to the governor for a signature. There is a chance that the clock runs out and the bill dies.
Derivative bans of any kind have the effect of discouraging investment. When the state moves to ban a new, prosperous market segment, the message it sends to the world is that innovation and opportunity is not welcome. It is indisputable that this ban puts the Texas extraction market at a significant disadvantage to other states. Common sense dictates anybody seeking to open an extraction facility will want it in a state that offers the most revenue opportunity.
We will continue to watch this issue and provide updates where appropriate. Please reach out if you have any questions or concerns.
Zachary Maxwell, President
HHS RESCINDS SCHEDULING RECOMMENDATION FOR KRATOM BUT FDA DELIBERATELY HID THAT FACT FOR MORE THAN 2 1⁄2 YEARS FROM THE PUBLIC, POLICY MAKERS AND THE MEDIA
HHS cites significant risk of immediate adverse public health consequences to potentially millions of users if kratom or its components are included in Schedule I
JANUARY 28, 2021-Washington, DC-Congressman Mark Pocan (WI) and Congressman Morgan Griffith, in exercising their oversight responsibilities over the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA), discovered that on August 16, 2018 HHS had rescinded the request for the kratom to be classified as a Schedule I substance under the Controlled Substances Act (CSA).
In the HHS letter to the Drug Enforcement Administration (DEA) HHS recommended that "mitragynine and 7-hydroxymitragynine not be controlled at this time, either temporarily or permanently, until scientific research can sufficiently support such an action." The FDA had made a recommendation for scheduling of kratom on August 31, 2016 that was subsequently withdrawn by the DEA on October 13, 2016 for insufficiency of evidence to support the scheduling under the CSA, and FDA submitted its second recommendation on October 17, 2017 that has been withdrawn by HHS because the scientific research did not justify the scheduling.
HHS concluded that "there is a significant risk of immediate adverse public health consequences to potentially millions of users if kratom or its components are included in Schedule I." The HHS letter outlined 5 specific criteria for "further analysis and public input regarding kratom" before any scheduling should be undertaken. Since the issuance of the recission letter, additional compelling research has further undermined the FDA's claims on the safety and abuse potential for kratom.
"Despite this formal action by HHS, the FDA has failed to make this action public and continued to allow the public; policy makers at the federal, state, and local levels; and the media to believe its recommendation for schedule kratom was actively being considered by DEA despite the fact the science did not support that action," stated Mac Haddow, Senior Fellow on Public Policy for the American Kratom Assocation (AKA). "The FDA abandoned its mandate to protect the public health and instead stood silent for more than 2 1⁄2 years while the opioid overdose crisis deepened, particulary in the midst of the spike in overdose deaths related on the ongoing COVID-19 pandemic, all while HHS had concluded kratom could have helped those using highly lethal opioids."
Hello Kratom King Family,
Upon beginning this endeavor, we had a decision to make, be the biggest supplier or be the BEST. After a few short months of opening, we saw an underserved niche in the industry, a higher quality product with the knowledge and passion for Kratom. It was then we decided on being the best instead of the largest and boy, are we glad we DID!
We fully understand that there are suppliers out there in our communities and hundreds of National and International online vendors from which to choose, however, we found no one to have the quality of products that we wanted to offer our customers when it comes to Kratom. Our strains are carefully curated from vendors that are not local and have agreed to exclusive contracts with only us! As you know, Exclusivity is important because you are getting a superior, safe, lab-tested, CONSISTENT product day in and day out. We understand our pricing may be different than some vendors that sell mixed, blended, even adulterated or simply lesser quality products, some of which contain alternative cuts of the leaf, stems and other organic (even non-organic) elements to make a larger profit. Look up Combretum quadrangulare, that is all we will say about that. We simply are not motivated by that approach.
With that being said, our products are not the same as any other Kratom products currently sold in the industry, even with the same name! It is because I named them myself! I tested and named them based on where they grow, how the leaves are dried and the colors for which they come. If you do find a product online with the same name i.e. "Gold Reserve, King Rush," We GUARANTEE that IT IS NOT our product, unless, it is our Kratom King brand and on our OWN website www.kratomkingtx.com. As of now, we do NOT distribute our Kratom to ANY other Suppliers and/or websites! Just keep that in mind.
We focus on the BEST supreme nano-kratom that is refined and lab reported safe with the HIGHEST alkaloid levels possible. We will continue to offer our best to the public with an unmatched in-store buying experience.
We love you; we care about you and appreciate each and every one of you!